IL2 and diabetes mellitus: Low dose IL-2 supplementation or Il2 protective allelic variation was shown to be sufficient to release the local deficiency of IL-2 in pancreatic islets, increase the number of Tregs and rebalance the Treg-Teff cell ratio in inflamed islets, thereby preventing the onset or reversing established diabetes eventually (42, 102–104).